[1]
Rahimi, F. et al. 2018. Using Discrete Choice Experiment to Determine Willingness to Pay for Interferon-Beta Drugs by Multiple Sclerosis Patients: Willingness to Pay for Interferon-Beta Drugs in Multiple Sclerosis Patients. Iranian Journal of Pharmaceutical Sciences. 14, 4 (Oct. 2018), 71–78. DOI:https://doi.org/10.22037/ijps.v14.40628.